Streams

Amgen To Buy Onyx In $10.4 Billion Deal

Tuesday, August 27, 2013

There's been a major acquisition in the drug industry. Amgen Inc, the world's largest biotechnology company is buying Onyx Pharmaceuticals. The deal is valued at $10.4 billion. Amgen has high hopes for Onyx's cancer drugs.

Source: NPR

Tags:

Leave a Comment

Email addresses are required but never displayed.

Get the WNYC Morning Brief in your inbox.
We'll send you our top 5 stories every day, plus breaking news and weather.